Key result
Bariatric surgery is linked to ~10% dynamic shifts in cf-mtDNA variants.
Why the study?
Cell-free mitochondrial DNA variants detected in plasma have potential utility as disease biomarkers, motivating an analysis of cf-mtDNA variants in healthy controls and obese bariatric surgery patients pre- and post-surgery using a novel deep sequencing and bioinformatics protocol.
Does bariatric surgery alter cell-free mitochondrial DNA variants in morbidly obese patients?
Observational (n=13)
Does bariatric surgery alter cell-free mitochondrial DNA variants in morbidly obese patients?
Bariatric surgery dynamically alters cell-free mitochondrial DNA variant profiles, with some pathogenic variants increasing in allele fraction post-surgery.
Answers are grounded in this paper and cite their sources.
Bariatric surgery-associated cf-mtDNA shifts including pathogenic increases should not change practice; hypothesis-generating for biomarker utility.
Introduction and Objective: Cell-free mitochondrial DNA (cf-mtDNA) variants detected in plasma have potential utility as biomarkers of disease. The objective of the current study was to analyze variants in cf-mtDNA using a novel deep sequencing and bioinformatics protocol in plasma from heathy controls (HC) and in obese bariatric surgery (OBS) patients pre- and post-surgery. Methods: Plasma cf-mtDNA was isolated from 9 morbidly OBS patients and 4 non-obese (BMI<30) HC. For each OBS patient, blood was collected at the pre-surgery and at one follow-up sample taken at either 2 weeks, 3 or 6 months after surgery. To obtain an accurate and comprehensive analysis of cf-mtDNA variants and distinguish nuclear mitochondrial (NUMTs) sequences in cf-mtDNA, a combined RNA target-bait enriched sequencing and bioinformatic protocol was applied. Variant allele fractions (VAF) were calculated for each patient variant. Results: Using the Fisher Test, no significant differences between pre-surgery OBS patients and HC were detected (p < 0.05). In post-surgery OBS patients, however, we identified a population of cf-mtDNA variants whose VAF decreased by ≥ 10% (n=10); these were characterized by apparently random variant signatures and have not been linked to pathology. Another population of cf-mtDNA variants displayed a ≥ 10% increase in VAF; these were predominately G>A nucleotide transitions (9/14), and included two previously confirmed pathogenic tRNA variants (tRNA Ile m.3,408G>A CPEO, and tRNA Gln m.4,332G>A, MELAS). Conclusion: Although definitive conclusions cannot be derived from this small pilot study, observations that variants increasing in VAF were characterized by G>A signature and have been implicated in pathology are conspicuous. These finding could inform future studies to test mutagenic mechanisms and selection pressures which could explain these observations. Identifying individual cf-mtDNA profiles could potentially guide personalized treatment approaches for obesity and insulin resistance. Disclosure G.T. Daly: None. M.N. Gillespie: None. W.O. Richards: Other - travel expenses for education; Current; Intuitive Surgical. Research Support; Current; Telabio. Research Support; Ended; Ethicon, Inc. L. Rachek: None.
No takes yet. Share an insight, caveat, or question.
Daly et al. (2026) conducted an observational in Obesity (n=13). Bariatric surgery vs. Pre-surgery baseline and healthy controls was evaluated on Differences in cf-mtDNA variant allele fractions (VAF). Bariatric surgery was associated with dynamic changes in cf-mtDNA, with some variants decreasing by ≥10% and others increasing by ≥10%, predominantly G>A transitions.
Synapse has enriched 10 related papers. Consider them for comparative context: